Type 2 diabetes mellitus (DM) has been shown to be a risk factor for the development of Alzheimer's disease (AD) and vascular dementia (VaD). In addition to AD and VaD, there may be a dementia subgroup associated with specific DM-related factors rather than with AD pathology or vascular diseases. This type of dementia, not showing hypoperfusion in the parietotemporal lobe on single photon emission CT or cerebrovascular lesions on magnetic resonance imaging, is characterized by high hemoglobin A 1c level, long duration of diabetes, high frequency of insulin therapy, low frequency of apolipoprotein E4 carrier, less severe medial temporal lobe atrophy, impaired attention and executive function, less impaired word recall, and slow progression of cognitive impairment, and might be referred to as diabetes-related dementia [1, 2] . This subtype of dementia accounts for at least 10% of all patients with dementia associated with DM. They often showed negative or equivocal amyloid accumulation in the brain on 11 C-Pittsburgh compound-B (PiB) positron emission tomography (PET) [2] . These findings suggest that underlying neuropathology in diabetesrelated dementia is not associated with AD pathologic changes, particularly amyloid pathology. In the present study, we analyzed cerebrospinal fluid (CSF) in individuals with diabetes-related dementia and those with AD and compared levels of phosphorylated tau (P-tau), β-amyloid 40 (Aβ40), and β-amyloid 42 (Aβ42).
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